vMIP-II (1-21) structure
|
Common Name | vMIP-II (1-21) | ||
---|---|---|---|---|
CAS Number | 265650-93-9 | Molecular Weight | 2425.84 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C108H169N33O27S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of vMIP-II (1-21)vMIP-II (1-21) is a CXCR4 antagonist. vMIP-II has broad-spectrum interaction with CC and CXC chemokine receptors. vMIP-II (1-21) binds with CXCR4 with an IC50 value of 190 nM for competing with CXCR4 binding of 125I-SDF-1R[1]. |
Name | vMIP-II (1-21) |
---|
Description | vMIP-II (1-21) is a CXCR4 antagonist. vMIP-II has broad-spectrum interaction with CC and CXC chemokine receptors. vMIP-II (1-21) binds with CXCR4 with an IC50 value of 190 nM for competing with CXCR4 binding of 125I-SDF-1R[1]. |
---|---|
Related Catalog | |
In Vitro | vMIP-II (1-21) (0.01-10 μM) 可与趋化因子受体 CXCR4 结合[1]。 vMIP-II (1-21) (25-200 μM) 抑制 CXCR4 介导 T 和双亲性 HIV-1 gp120 介导的细胞-细胞融合[1]。 vMIP-II (1-21) (100 μM) 剂量依赖性地抑制的趋化活性[1]。 |
References |
Molecular Formula | C108H169N33O27S |
---|---|
Molecular Weight | 2425.84 |